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Abstract
Background:  Monomeric GTPases of the Rho family control a variety of cellular functions
including actin cytoskeleton organisation, cell migration and cell adhesion. Defects in these
regulatory processes are involved in tumour progression and metastasis. The development of
metastatic carcinoma is accompanied by deregulation of adherens junctions, which are composed
of E-cadherin/β- and α-catenin complexes.
Results: Here, we show that the activity of the monomeric GTPase Rac1 contributes to inhibition
of E-cadherin-mediated cell-cell adhesion in pancreatic carcinoma cells. Stable expression of
constitutively active Rac1(V12) reduced the amount of E-cadherin on protein level in PANC-1
pancreatic carcinoma cells, whereas expression of dominant negative Rac1(N17) resulted in an
increased amount of E-cadherin. Extraction of proteins associated with the actin cytoskeleton as
well as coimmunoprecipitation analyses demonstrated markedly decreased amounts of E-cadherin/
catenin complexes in Rac1(V12)-expressing cells, but increased amounts of functional E-cadherin/
catenin complexes in cells expressing Rac1(N17). Cell aggregation and migration assays revealed,
that cells containing less E-cadherin due to expression of Rac1(V12), exhibited reduced cell-cell
adhesion and increased cell motility. The Rac/Cdc42 effector protein IQGAP1 has been implicated
in regulating cell-cell adhesion. Coimmunoprecipitation studies showed a decrease in the
association between IQGAP1 and β-catenin in Rac1(V12)-expressing PANC-1 cells and an
association of IQGAP1 with Rac1(V12). Elevated association of IQGAP1 with the E-cadherin
adhesion complex via β-catenin correlated with increased intercellular adhesion of PANC-1 cells.
Conclusion: These results indicate that active Rac1 destabilises E-cadherin-mediated cell-cell
adhesion in pancreatic carcinoma cells by interacting with IQGAP1 which is associated with a
disassembly of E-cadherin-mediated adherens junctions. Inhibition of Rac1 activity induced
increased E-cadherin-mediated cellular adhesion.
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Background
Strong cell-cell adhesion is a characteristic element of epi-
thelial cells and its assembly and maintenance is part of
the cellular differentiation and polarisation process of epi-
thelial cells and tissues. Loss of cellular adhesion accom-
panied by loss of the underlying protein modules is
frequently observed during metastasis of tumours of dif-
ferent origin and results in cellular dedifferentiation and
gain of migratory properties of tumour cells [1,2]. The
adherens junctions are the best known cell-cell adhesion
modules which are responsible for the strong mechanical
intercellular adhesion, especially in epithelial tissues.
Adherens junctions are mainly built by homophilic inter-
actions of proteins of the cadherin family which are trans-
membrane calcium-dependent adhesion proteins with E-
cadherin as its best characterised member [3].
The association of E-cadherin with the actin cytoskeleton
is necessary for strong mechanical cell-cell interaction.
This interaction is mediated via E-cadherin-bound β-cat-
enin and α-catenin, which in turn is associated with actin
filaments by actin-binding proteins like Eplin, vinculin,
formin-1 or α-actinin [4,5]. The assembly of the E-cad-
herin/catenin adhesion complex is under tight control
which involves different posttranscriptional processes like
phosphorylation and dephosphorylation, protein interac-
tions and the alteration of protein stability [6]. Moreover,
the association of the E-cadherin complex with the actin
cytoskeleton is likewise tightly controlled and requires the
regulated assembly of actin filaments at sites of cell-cell
contacts [7]. The important role of the Rho family mem-
ber Rac1 in this process has been demonstrated in several
reports and is reviewed in [8]. The active, GTP-bound
form of Rac1 regulates the formation of submembraneous
actin cytoskeleton structures, resulting in the formation of
lamellipodia [9]. The localisation of activated Rac1 at
membrane sites is a necessary step in the maturation of
adherens junctions of epithelial cells during cell polarisa-
tion [10]. The molecular mechanism by which Rac1 medi-
ates actin cytoskeletal organisation in epithelial cells is
not totally clear yet. The involvement of the Rac1 activator
Tiam1, a guanine nucleotide exchange factor, as well as
the Rac1 effector IQGAP1 has been documented [11,12].
The IQGAP family comprises a small group of eukaryotic
proteins, namely IQGAP1, IQGAP2 and IQGAP3, with
IGGAP1 and 2 sharing 62% similarity in the amino acid
sequence [13]. IQGAP1 colocalises with actin in lamel-
lipodia and membrane ruffles [14]. Because IQGAP1 and
2 contain several protein interacting domains they are
suggested to function as scaffolds coordinating different
signalling processes [15]. Several studies have shown the
importance of IQGAP proteins for the formation and mat-
uration of E-cadherin-mediated cell-cell adhesion com-
plexes. [16-18]. Moreover, published data confirm an
association of IQGAPs with the E-cadherin/catenin adhe-
sion complex [19].
With regard to human cancers pancreatic ductal adenocar-
cinoma belong to the most fatal cancers because of their
very early onset and high frequency of metastasis forma-
tion [20]. The molecular mechanism responsible for this
extraordinary high rate of metastasis is not known so far.
It is documented that Rho GTPases participate in the
induction of transformation and metastasis by regulating
the organisation of the cytoskeleton as well as gene tran-
scription. [21-23].
In the present manuscript the role of the GTPase Rac1 on
E-cadherin-mediated adherens junctions and on cell
migration and adhesion was analysed in Rac1(V12)- and
Rac1(N17)-expressing PANC-1 cells. We show that
enhanced expression of active Rac1(V12) reduces cell-cell
adhesion and increases directed cell motility and migra-
tion through extracellular matrix, while dominant nega-
tive Rac1(N17) mediates the opposite effects. Moreover,
activated Rac1(V12) binds to IQGAP1 which is linked to
a reduced association of IQGAP1 to β-catenin. These alter-
ations are associated with a disassembly of the E-cad-
herin/catenin adhesion complex resulting in inhibited
cellular aggregation and elevated migratory capacity of
pancreatic carcinoma cells. These results suggest that
active Rac1 destabilises E-cadherin-mediated cell-cell
adhesion in pancreatic carcinoma cells by interacting with
IQGAP1 and induction of the disassembly of the E-cad-
herin/catenin complex. Thus, the data support a role of
Rac1 in inhibition of cellular adhesion allowing metasta-
sis formation of pancreatic adenocarcinoma.
Materials and methods
Cell culture and transfection
PANC-1 pancreatic carcinoma cells were obtained from
ATCC and maintained in DMEM with 10% fetal calf
serum (Invitrogen). PANC-1 cells stably transfected with
pEGFP/HA-Rac1(V12), pEGFP/Rac1(N17) or pEGFP-C3
(Clontech) were established as described before [24,25].
EGFP- and EGFP-Rac1-expressing cell clones were main-
tained in growth medium supplemented with 1.5 mg/ml
G418 (PAA Laboratories). IQGAP1 protein expression
was inhibited by specific double-stranded siRNAs (Qia-
gen), designed by using Qiagen online siRNA design tool
according to the published sequence. Two unrelated
siRNA oligonucleotides were used: IQGAP1 si1: gacu-
uacugcagaggagau; IQGAP1 si2: ugccauggaugagauugga. As
control siRNA an oligonucleotide was used without any
homology to any known mammalian gene (Qiagen, All-
Stars neg. Control). Cells were transfected with 66 nM
siRNA using DMRIE-C transfection reagent (Invitrogen)
and protein expression was analysed after 36-48 h by
Western blotting. Cellular proteolytic enzymes were
inhibited by treating cultured cells with the permeable
pharmacological inhibitors E64 (Roche Diagnostics, 1.5
μM) and MG132 (Calbiochem, 1 μM) for 36 h.Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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Antibodies
Monoclonal antibodies against E-cadherin, α- and β-cat-
enin, and Rac1 were obtained from BD Bioscience, mon-
oclonal antibody against GFP was from Roche
Diagnostics, polyclonal antibody against β-catenin and
monoclonal antibody against β-actin were from Sigma-
Aldrich.
Protein analysis and GST-pull down assays
Cell lysis, SDS gel electrophoresis and Western blotting
procedure were performed as described before [23].
Briefly, cells were lysed in NOP buffer [50 mM Tris/HCl
(pH 7.2), 1% Triton X-100, 1% NP-40, 150 mM NaCl,
containing 400 μM aprotinin, 50 μM leupeptin, and 0.5
mM Pefabloc (all from Roche Diagnostics)] to inhibit
proteases. Thirty microgram of total lysates were analysed
by SDS-PAGE, blotted onto nitrocellulose and incubated
with the indicated antibody over night and a HRP-
labelled secondary antibody. Immunoreactive proteins
were visualised using an enhanced chemiluminescence
detection system (Pierce). Detection of β-actin served to
control for equal loading.
For coimmunoprecipitation experiments, 0.5-3 mg of
NOP-lysate was used for the μMACS protein isolation sys-
tem (Miltenyi Biotec) according to manufacture's instruc-
tions using the appropriate antibodies.
Immunoprecipitates were analysed by Western blotting.
For GST-pull down assays the cDNA of β-catenin was
ligated in frame into the GST-vector pGEX-4T1 (GE
Healthcare-Amersham), expressed in E. coli DH5α and
isolated as described before in [26]. Confluent cells were
washed with ice-cold TBS (50 mM Tris/HCl, pH 7.5, 150
mM NaCl) and lysed in RIPA buffer (50 mM Tris-HCl pH
7.4, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deox-
ycholate, 0.5% SDS) including proteinase inhibitors as
indicated above. For the assay 500 μg of total protein was
mixed with 20-40 μg GST-fusion protein immobilised to
glutathione sepharose for 60 min at 4°C. One tenth of the
lysate used for precipitation was removed before adding
GST-fusion protein and analysed by Western blotting for
equal amounts of IQGAP1 and the stably expressed EGFP
or EGFP-Rac1 proteins. The amount of IQGAP1 associ-
ated with GST-β-catenin was analysed by Western blot-
ting. Representative blots out of three or more
independent experiments are shown.
Immunocytochemical analysis
Cells were seeded on coverslips, fixed in 4% paraformal-
dehyde and 20% acetic acid for 15 min and permeabilised
with 0.1% Triton X-100 in PBS for 10 min for staining of
IQGAP1, Rac1 and filamentous actin (F-actin). For the
staining of E-cadherin or β-catenin, cells were fixed with
ice-cold methanol/acetone 1:1 for 15 min. The first anti-
bodies were applied for 60 min at 37°C followed by a
Cy3-coupled secondary antibody (Dianova) for 30 min at
37°C. F-actin was visualised using CPTIC (coumarin phe-
nyl isothiocyanate)-conjugated phalloidin (Sigma-
Aldrich). Staining was examined using an IX70 fluores-
cence microscope (Olympus). Images were processed
with AnalySIS 3.2 software (Soft-Imaging System).
RT-PCR studies
Two-step RT-PCR was performed as described before [27].
RNA was extracted using the RNeasy Mini Kit (Qiagen).
To produce cDNA of the used cell clones, 1 μg of total
mRNA was transcribed using random primers and Super-
script II reverse transcriptase (Invitrogen) in a volume of
50 μl. The semi-quantitative PCR was performed with spe-
cific primers for E-cadherin and β-actin using 1 μl of 1/10
diluted cDNA [27].
Migration, invasion and aggregation studies
Migration, invasion and aggregation assays were per-
formed as described in Vogelmann et al. [28]. The number
of cells which had migrated through uncoated (8.0 μm
pore size, BD Bioscience) or collagen type I-coated tran-
swell inserts (8.0 μm pore size coated with 70 μl collagen
type I solution (0.2 mg/ml, BD Bioscience) was estimated
36 h after seeding of PANC-1 cells stably expressing EGFP,
EGFP-Rac1(V12) or EGFP-Rac1(N17). The number of
cells which had migrated to the bottom compartment
containing DMEM + 10% FCS was estimated by counting
three independent, randomly chosen visual fields in a
phase contrast microscope (magnification 20×). Three
independent assays were performed in duplicate.
To determine the cell-cell adhesion capacity, cell rotation
aggregation assays were performed as described in [28].
The aggregation index was calculated from the ratio of the
aggregate number after 30 min of rotation and the particle
number at the beginning (Ai = (N0-N30)/N0). Five inde-
pendent assays were performed in duplicate.
Subcellular fractionation
For subcellular fractionation into soluble (S100) and par-
ticulate membrane-containing (P100) fractions, conflu-
ent cells were scraped into 500 μl HEPES buffer [50 mM
HEPES, pH 7.6, 8.6% (m/v) sucrose, 10 mM EDTA, 10
mM EGTA, 1 mM Pefabloc, 40 μg/μl leupetin, 0.4 mg/ml
soybean trypsin inhibitor, 40 μg/ml pepstatin A] and frac-
tionated by high speed centrifugation as described in [23].
To obtain Triton X-100-soluble and -insoluble fractions,
cells were incubated with Triton-lysis buffer (1% Triton X-
100, 0.3 M sucrose, 25 mM HEPES, pH 7.4, 100 mM
NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgCl2, 5
μM aprotinin, 1 mM Pefabloc, 5 μM soybean trypsin
inhibitor) for 15 min on a rocking platform as described
in [28]. The Triton-soluble and the Triton-insoluble frac-Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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tions were reconstituted to equal volumes and 15 μl of
each fraction were analysed by Western blotting.
Rac1 activity assay
The amount of GTP-bound Rac1 was determined by using
the CRIB-domain of PAK1B (GST-PAK) as an activation-
specific probe for activated Rac1 as described in [25].
Statistics
To analyse statistical differences means and standard error
means (SEM) were compared using the unpaired student
t-test and Prism 4 software (GraphPad Software, Inc.).
Results
Expression of EGFP-Rac1(V12) and EGFP-Rac1(N17) in 
pancreatic carcinoma cells
The aim of this study was to characterise the function of
Rac1 in epithelial cell differentiation and migration, espe-
cially during carcinogenesis of pancreatic cancer cells.
Therefore, we stably expressed constitutively active EGFP
(enhanced green fluorescent protein)-Rac1(V12) or dom-
inant negative EGFP-Rac1(N17) in the pancreatic carci-
noma cell line PANC-1. PANC-1 clones stably expressing
EGFP served as control. The expression of EGFP and
EGFP-Rac1 proteins was analysed by immunoblotting of
lysates of the obtained cell clones and 2-4 clones for each
protein were selected for further investigation. Approxi-
mately 90% of cells of the selected clones showed EGFP or
EGFP-Rac1 expression. Since the number of EGFP-Rac1-
expressing cells decreases in the course of long term cul-
ture, the number of fluorescent cells was controlled regu-
larly. If necessary the culture was replaced by a culture of
a low passage number to keep high numbers of EGFP-
Rac1-expressing cells. Data of one representative cell clone
expressing EGFP [clone EGFP-21], EGFP-Rac1(V12)
[clone Rac1(V12)-10.1] or EGFP-Rac1(N17) [clone
Rac1(N17)-2] are shown in all figures.
Figure 1A shows the localisation of the ectopically
expressed EGFP and EGFP-Rac1 proteins and documents
that both Rac1 mutants were equally expressed. The dom-
inant negative EGFP-Rac1(N17) is mainly localised at the
cell membrane and is concentrated in areas of cell-cell
contacts (Figure 1A). The membranous localisation of
EGFP-Rac1(N17) was confirmed by subcellular fractiona-
tion of total cell lysate in a soluble fraction containing
cytosolic proteins and a particulate, membrane-contain-
ing fraction (as demonstrated later in Figure six A). The
stably expressed constitutively active EGFP-Rac1(V12)
was localised in the membrane and the cytoplasm of the
cells (Figure 1A). Immunofluorescence staining of endog-
enous Rac1 (Figure 1B) demonstrate that endogenous
Rac1 is localised at the plasma membrane and in the cyto-
plasm of PANC-1 cells. This distribution was also evident
after subcellular fractionation and Western blotting
Expression of EGFP-Rac1(V12) and EGFP-Rac1(N17) in  PANC-1 cells Figure 1
Expression of EGFP-Rac1(V12) and EGFP-Rac1(N17) 
in PANC-1 cells. (A) Localisation of EGFP-Rac1(V12) and 
EGFP-Rac1(N17). EGFP fluorescence (upper panel) and 
phase contrast analyses (lower panel) demonstrate the local-
isation of EGFP proteins and the morphology of subconflu-
ent, living PANC-1 cells stably expressing EGFP, EGFP-
Rac1(V12) and EGFP-Rac1(N17), bar = 20 μm. (B) Immun-
ofluorescence analysis of Rac1 localisation. Fixed EGFP-, 
EGFP-Rac1(V12)- and EGFP-Rac1(N17)-expressing cells 
were incubated with Rac1-specific antibody. EGFP fluores-
cence is illustrated for comparison (bar = 30 μm). (C) 
Expression of EGFP, EGFP-Rac1 and endogenous Rac1 in 30 
μg of total cell lysate of different cell clones was estimated by 
Western blotting using Rac1- and GFP-specific antibodies. 
One representative blot of three independent experiments is 
shown. (D) The amount of active Rac1-GTP in EGFP- and 
EGFP-Rac1-expressing cells was determined by affinity pre-
cipitation assays (upper panel). The cells were serum-starved 
for 24 h and then left untreated (-) or treated with 10 ng/ml 
PDGF AB for 5 min (+). The assay was performed with 500 
μg (Rac1) or 1000 μg (EGFP-Rac1) of cell lysate. To control 
for equal loading, aliquots of the samples were analysed in 
parallel in Western blotting (lower panel). One representa-
tive blot out of three independent experiments is shown.Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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EGFP-Rac1-induced differences in the amount of cell-cell adhesion protein concentration Figure 2
EGFP-Rac1-induced differences in the amount of cell-cell adhesion protein concentration. (A) The amount of E-
cadherin, α- and β-catenin in 30 μg of total cell lysate was analysed by Western blotting. Individual proteins were detected by 
using specific antibodies. Detection of β-actin served as control to document equal amounts of protein in each lane.(B+C) The 
amount of the E-cadherin/catenin complex was analysed by immunoprecipitation of β-catenin (B) or E-cadherin (C) from 300 
μg of total cell lysate. Coprecipitated E-cadherin and α-catenin (B) or α-catenin and β-catenin (C), respectively, were identi-
fied by Western blotting. (D) Reverse transcription-PCR analysis was performed using total RNA isolated from PANC-1 cells 
stably expressing EGFP, EGFP-Rac1(N17) or EGFP-Rac1(V12). E-cadherin mRNA was amplified using specific primers. Amplifi-
cation of β-actin cDNA served as control to document equal amounts of mRNA. (E) Association of the E-cadherin/catenin 
complex with the actin cytoskeleton was analysed using Triton X-100-fractionated cell extracts. Amounts of E-cadherin and β-
catenin were analysed by Western blotting using 10 μg of Triton X-100-soluble and Triton X-100-insoluble fraction. (F) To 
investigate the influence of endogenous active Rac1 on the E-cadherin/catenin complex, PANC-1 cells were treated with 50 
μM of the Rac1-inhibitor NSC23766 or stimulated for 5 min with PDGF AB (10 ng/ml). Active Rac1-GTP was precipitated 
from 800 μg of cell lysates by affinity precipitation assays (upper panel). To control for equal loading, aliquots of the samples 
were analysed in parallel (lower panel). The amount of E-cadherin/catenin complexes was analysed by detection of E-cadherin, 
which was coprecipitated with β-catenin from 500 μg of total cell lysates. (G) To investigate E-cadherin degradation in 
Rac1(V12)-expressing PANC-1 cells, cells were incubated with MG132 (1 μM) or E64 (1.5 μM) to suppress proteolytic degra-
dation of proteins. The amount of E-cadherin was estimated by Western blotting using 30 μg of total protein lysates. Determi-
nation of β-actin served to control for comparable loading. In each figure one representative blot/agarose gel of three to four 
independent experiments is shown.Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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shown later in Figure six A. The obtained results are in
agreement with the localisation of Rac1 and EGFP-Rac1
mutants in MDCK and COS1 cells [29].
Western blot analyses confirmed the expression of Rac1
fusion proteins of the expected size (approximately 50
kDa for EGFP-Rac1 and 30 kDa for EGFP) (Figure 1C) as
exemplified for two EGFP-Rac1(N17) and three EGFP-
Rac1(V12) cell clones. Two EGFP-expressing clones served
as controls. The various bands seen at a molecular weight
< 30 kDa are most likely degradation products of EGFP-
Rac1 detected by the GFP antibody. The amount of endog-
enous Rac1 was not altered by the expression of the EGFP-
Rac1 mutants. To analyse the activity of endogenously
and ectopically expressed Rac1 in serum-starved and
PDGF AB-treated cells, affinity precipitation assays were
performed using the Rac1-binding domain of PAK1B as
an activation-specific probe to isolate Rac1-GTP. As dem-
onstrated in Figure 1D only EGFP-Rac1(V12) was precip-
itated and therefore active, whereas dominant negative
EGFP-Rac1(N17) was not precipitated (Figure 1D). Treat-
ment of the cells with 10 ng/ml PDGF AB for 5 min
resulted in activation of endogenous Rac1 in the EGFP-
expressing control cells and the EGFP-Rac1(V12)-express-
ing cells, whereas the constitutively active EGFP-
Rac1(V12) was not further activated. The activity of
endogenous Rac1 in cells expressing the dominant nega-
tive EGFP-Rac1(N17), which is reduced as compared to
the activity in EGFP- and EGFP-Rac1(V12)-expressing
cells, was not increased by PDGF AB, demonstrating the
inhibitory effect of this mutant on Rac1 activation.
Rac1(V12) decreases E-cadherin adhesion complexes in 
PANC-1 cells
Because EGFP-Rac1 was localised in areas of cell-cell con-
tacts which might interfere with the E-cadherin-mediated
cell-cell adhesion, the effects of Rac1 expression on the
intercellular adhesion was analysed. First, the concentra-
tion of E-cadherin/catenin complex proteins was compar-
atively analysed in total cell lysates of EGFP-, EGFP-
Rac1(N17)- and EGFP-Rac1(V12)-expressing PANC-1
cells. As shown in Figure 2A, PANC-1 cells expressing
EGFP-Rac1(N17) exhibited increased concentrations of E-
cadherin and β-catenin and equal amounts of α-catenin
in total cell lysates compared to EGFP-expressing controls.
In contrast, cells expressing constitutively active EGFP-
Rac1(V12) showed dramatically reduced amounts of E-
cadherin and α-catenin and slightly reduced amounts of
β-catenin (Figure 2A). Detection of EGFP and Rac1 con-
firmed comparable amounts as well as the presence and
correct size of ectopically expressed EGFP and EGFP-Rac1
as well as endogenous Rac1 (Figure 2A). Staining of β-
actin served to control for equal amounts of protein used
in each lane. To determine whether the increased amount
of E-cadherin was due to enhanced gene expression, the
amount of E-cadherin mRNA was analysed by RT-PCR. As
demonstrated in Figure 2D only minor differences in the
amount of the E-cadherin mRNA were detected between
the analysed cell clones pointing to a regulation of the
amount of E-cadherin on the protein level.
To achieve intercellular adhesion, E-cadherin needs to be
assembled in cadherin/catenin complexes. To estimate
the amount of E-cadherin/catenin complexes present in
EGFP-Rac1-expressing PANC-1 cells, coimmunoprecipita-
tion experiments were performed. Immunoprecipitation
of equal amounts of β-catenin and staining of coprecipi-
tated E-cadherin and α-catenin revealed a significant
increase in the amount of coprecipitated E-cadherin and
α-catenin in cells expressing EGFP-Rac1(N17) compared
to EGFP-expressing controls (Figure 2B). In contrast,
reduced amounts of E-cadherin and α-catenin were asso-
ciated with β-catenin in EGFP-Rac1(V12)-expressing
PANC-1 cells, indicating reduced amounts of E-cadherin
adhesion complexes (Figure 2B). These changes were con-
firmed by immunoprecipitating E-cadherin and detection
of associated α- and β-catenin (Figure 2C).
Furthermore, the association of the cadherin/catenin
complex with the actin cytoskeleton is indispensable for
strong cell-cell interactions. To analyse the amount of E-
cadherin/catenin complexes which are associated with the
cytoskeleton, the distribution of E-cadherin, α- and β-cat-
enin was determined in Triton X-100-fractionated cell
lysates. Triton X-100 fractionation separates cytoskeletal
and cytoskeleton-associated proteins, which are present in
the Triton-insoluble fraction, from soluble and cytoplas-
mic proteins, enclosed in the Triton-soluble fraction [30].
As demonstrated in Figure 2E, expression of the constitu-
tively active EGFP-Rac1(V12) correlated with reduced lev-
els of cytoskeleton-bound E-cadherin, whereas the
expression of dominant negative EGFP-Rac1(N17)
resulted in an increased amount of Triton-insoluble,
cytoskeleton-bound E-cadherin and β-catenin (Figure
2E). The decrease in the amount of E-cadherin and β-cat-
enin in the Triton-soluble fraction of the EGFP-
Rac1(N17)-expressing cells suggests a stabilising effect of
the dominant negative Rac1 mutant on the E-cadherin
complex and its association with the cytoskeleton.
Next, we analysed whether inhibition or activation of
endogenous Rac1 provokes similar effects in the E-cad-
herin adhesion complex. Therefore, Rac1 activity was
either inhibited by treatment of PANC-1 cells with a Rac1
inhibitor NSC23766 (50 μM) [31] for 16 h or stimulated
by incubation of the cells with the growth factor PDGF AB
[32] for 5 min. Rac1 activity assays (Figure 2F) demon-
strate that the Rac1 inhibitor suppressed the activity ofCell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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endogenous Rac1 in PANC-1 cells. PDGF AB enhanced
the amount of active Rac1, thereby verifying the appropri-
ate effects of the two substances. Next, the amount of E-
cadherin which coprecipitated with β-catenin was ana-
lysed by coimmunoprecipitation and Western blot proce-
dure. As shown in Figure 2F, activation of Rac1 by PDGF-
treatment clearly reduced the concentration of the E-cad-
herin/catenin complexes, as demonstrated by the reduced
E-cadherin amount. However, inhibition of Rac1 by treat-
ment with the Rac1 inhibitor for 16 h increased the
amount of E-cadherin which was coprecipitated with β-
catenin. These data are in agreement with the results
shown before, which demonstrated a detachment of E-
cadherin from the actin cytoskeleton in PANC-1 cells after
ectopic expression of constitutively active Rac1(V12) and
an increased association after expression of dominant
negative Rac1(N17). The lower amount of E-cadherin in
EGFP-Rac1(V12)-expressing cells was not due to reduced
gene expression as shown above. Thus, we asked whether
an increased degradation of E-cadherin may be responsi-
ble for the altered E-cadherin level. EGFP-Rac1(V12)-
expressing PANC-1 cells were treated with the proteolytic
inhibitors E64 and MG132 for 36 h. The Western blots
demonstrated in Figure 2G, clearly show increased
amounts of E-cadherin in inhibitor-treated EGFP-
Rac1(V12) cells. Therefore, these results points to an ele-
vated proteosomal degradation of E-cadherin in EGFP-
Rac1(V12)-expressing PANC-1 cells.
Activated Rac1 inhibits cell aggregation and promotes cell 
migration
Next, we investigated the consequence of the Rac1-modu-
lated E-cadherin/catenin amounts and complex stability
on cell-cell adhesion, cell migration and invasion of
PANC-1 cells stably expressing EGFP, EGFP-Rac1(V12) or
EGFP-Rac1(N17). The influence of Rac1 on cell-cell adhe-
sion was determined by rotation aggregation assays. As
shown in Figure 3, dominant negative Rac1(N17)
enhanced the cellular aggregation of PANC-1 cells statisti-
cally significant (p < 0.02, Student t-Test) compared to the
control cells. In contrast, constitutively active Rac1(V12)
significantly reduced the cell aggregation capacity of
PANC-1 cells (p < 0.05, Student t-Test). These data dem-
onstrate that the Rac1-induced alteration in the amount
and association of the E-cadherin/catenin complex
reported above are reflected by changes in cell-cell adhe-
sion.
Because a reduction of cell-cell adhesion is frequently
observed in migrating epithelial cells, the influence of the
Rac1 mutants was analysed on cellular motility. Directed
cell migration was studied using uncoated transwell cell
migration chambers. Figure 3 demonstrates that PANC-1
cells expressing dominant negative EGFP-Rac1(N17) and
therefore increased amounts of E-cadherin adhesion com-
plexes, exhibit a significant reduction of cell migration as
compared to the EGFP-expressing control cells. Expres-
sion of EGFP-Rac1(V12) resulted in a nearly two-fold
increase in the number of migrated cells compared to
EGFP-transfected PANC-1 cells (Figure 3). The same ten-
dency was observed when collagen type I-coated cham-
bers were used. EGFP-Rac1(V12)-expressing cells
exhibited a markedly increased cell invasion through col-
lagen I matrix, whereas EGFP-Rac1(N17)-expressing cells
showed a slightly inhibited cell invasion through the col-
lagen matrix (Figure 3).
Rac1(V12) alters the localisation of IQGAP1
The changes in the amount of E-cadherin/catenin com-
plexes and the subsequently increased cell migration cor-
relates with the localisation of E-cadherin, β-catenin and
filamentous actin, as determined by immunofluorescence
analyses (Figure 4A). EGFP-Rac1(N17)-positive PANC-1
cells showed enhanced E-cadherin staining as well as
enhanced β-catenin staining, which predominantly local-
ised in areas of cell-cell-contacts. The Rac1(V12)-express-
ing cells showed a reduced and punctuated E-cadherin
staining and diminished β-catenin fluorescence compared
to EGFP- and EGFP-Rac1(N17)-expressing cells, especially
in the areas of cell-cell contacts. This redistribution of β-
catenin correlated with changes in the organisation of
actin filaments. A loss of cortical actin and an increase in
short actin filaments beneath the plasma membrane was
Rac1 influences the cell aggregation and cell migration of  PANC-1 cells Figure 3
Rac1 influences the cell aggregation and cell migra-
tion of PANC-1 cells. Cell-cell adhesion of PANC-1 cells 
stably expressing EGFP, EGFP-Rac1(V12) or EGFP-
Rac1(N17) was analysed by rotation aggregation assays. Cell 
migration was studied using uncoated transwell migration 
assays. The number of migrated cells in three randomly cho-
sen visual fields (magnification 20×) is given. Cell migration 
through extracellular matrix was analysed using collagen type 
I-coated transwell inserts. Mean +/- SEM of three independ-
ent assays performed in duplicate is shown. Statistical differ-
ences were analysed compared to EGFP-expressing controls 
using the unpaired student t-test and (*) p < 0.05 was consid-
ered significant.
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observed in EGFP-Rac1(V12)-expressing PANC-1 cells
(Figure 4A and 4B).
Most interestingly, the Rac1 effector IQGAP1, formerly
described as a GTPase activating protein (GAP) for Rac
[33], also showed a differential localisation in PANC-1
cells depending on Rac1 activity. In the EGFP-expressing
controls as well as in EGFP-Rac1(N17)-expressing cells,
IQGAP1 was localised mainly at or near the plasma mem-
brane and was concentrated in areas of cell-cell contacts
(Figure 4A). In PANC-1 cells expressing constitutively
active EGFP-Rac1(V12) IQGAP1 colocalised with the
short actin filaments (Figure 4A and 4B). This colocalisa-
tion of IQGAP1 and F-actin becomes evident in the
enlarged micrographs and the merged image shown in
Figure 4B, in which the yellow colour indicates similar
localisation of the two proteins.
Rac1(N17) promotes the interaction between  -catenin 
and IQGAP1 in PANC1-cells
The different localisation of IQGAP1 observed in immun-
ofluorescence studies of PANC-1 cells harbouring differ-
ent Rac1 mutants was further analysed in
coimmunoprecipitation experiments. IQGAP1 was coim-
munoprecipitated with β-catenin from lysates of cells
expressing dominant negative EGFP-Rac1(N17) (Figure
5A). In cells expressing constitutively active EGFP-
Rac1(V12) only small amounts of β-catenin were copre-
cipitated with IQGAP1 (Figure 5A, left panel). But immu-
noprecipitation of EGFP-Rac1 resulted in the case of
EGFP-Rac1(V12) in high amounts of coprecipitated
IQGAP1 (Figure 5A, right panel) in contrast to precipita-
tion of EGFP-Rac1(N17) where only small amounts of
IQGAP1 were coprecipitated (Figure 5A, right panel).
The interaction between β-catenin and IQGAP1 was con-
firmed by in vitro binding experiments. Bacterially
expressed GST-β-catenin was incubated with cell lysates of
PANC-1 cells stably expressing EGFP, EGFP-Rac1(V12) or
EGFP-Rac1(N17). IQGAP1 was purified by GST-β-catenin
only from lysates of cells expressing EGFP-Rac1(N17) but
not form lysates of EGFP-Rac1(V12)-expressing cells (Fig-
ure 5B). Aliquots of the used cell lysates were analysed to
confirm the presence of equal amounts of IQGAP1 and of
the EGFP-proteins (Figure 5B).
IQGAP1 interacts with  -catenin in the membrane fraction 
of Rac1(N17)-expressing pancreatic epithelial cells
In order to determine the localisation and composition of
the IQGAP1-, β-catenin-, Rac1-complexes in more detail
coimmunoprecipitation studies with subcellular fractions
of cell lysates were performed. Soluble (S100) and partic-
ulate (P100) fractions of EGFP-, EGFP-Rac1(V12)- and
EGFP-Rac1(N17)-expressing PANC-1 cells were obtained
by high speed centrifugation at 100000 × g. The particu-
late fraction contains membranes and membrane-associ-
ated proteins and the soluble fraction enclose cytoplasmic
proteins. Figure 6A shows the distribution of IQGAP1, β-
catenin and Rac1 proteins in the two subcellular fractions
of the different PANC-1 cell clones. IQGAP1 and endog-
enous Rac1 were present in both the S100 and the P100
fraction and this distribution was not influenced by the
expression of EGFP-Rac1(V12) or EGFP-Rac1(N17). β-
catenin was also present in both S100 and P100 fractions,
but higher amounts were detectable in the fractions pre-
pared from EGFP-Rac1(N17)-expressing PANC-1 cells as
compared to the controls. This increase is in agreement
with the enhanced amount of β-catenin in total lysates of
Immunofluorescence localisation of E-cadherin, β-catenin,  IQGAP1 and filamentous actin (F-actin) Figure 4
Immunofluorescence localisation of E-cadherin, β-
catenin, IQGAP1 and filamentous actin (F-actin). (A) 
PANC-1 cells stably expressing EGFP, EGFP-Rac1(V12) or 
EGFP-Rac1(N17) were incubated with specific antibodies 
against E-cadherin, β-catenin, IQGAP1 or CPTIC-conjugated 
phalloidin. The staining was examined by fluorescence micro-
scopy (bar = 20 μm). (B) EGFP-Rac1(V12)-expressing 
PANC-1 cells were stained for IQGAP1 and F-actin with 
CPTIC-conjugated phalloidin. The merged image shows in 
yellow the colocalisation of IQGAP1 and filamentous actin 
(bar = 10 μm).Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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EGFP-Rac1(N17)-expressing cells. The EGFP-Rac1
mutants showed a differential distribution. Whilst EGFP-
Rac1(N17) was detected only in the particulate, mem-
brane containing P100 fraction, EGFP-Rac1(V12) was
localised in both the S100 and the P100 fraction. These
results indicate that the distribution of the constitutive
active and the dominant negative mutant of Rac1 is differ-
entially regulated in the cells. The coimmunoprecipitation
experiments, shown in Figure 6B and 6C, led to the fol-
lowing results. IQGAP1-immunoprecipitates revealed
that β-catenin was only coprecipitated from the particu-
late, membrane-containing fraction. Interestingly, the
highest amount of IQGAP1/β-catenin complexes was pre-
cipitated from the particulate fraction of EGFP-
Rac1(N17)-expressing cells, whereas only minor quantity
of β-catenin was coprecipitated with IQGAP1 from the
particulate fraction of EGFP-Rac1(V12)-expressing cells
(Figure 6B upper panel). Moreover, when the amount of
EGFP-Rac1 which coprecipitated with IQGAP1 (Figure 6B
middle panel) was analysed, it was obvious that only
membrane-associated EGFP-Rac1(N17) interacted with
IQGAP1. In contrast, EGFP-Rac1(V12)/IQGAP1 com-
Interaction of IQGAP1 with Rac1 or β-catenin Figure 5
Interaction of IQGAP1 with Rac1 or β-catenin. (A) 
IQGAP1 was precipitated from lysates of EGFP-, 
EGFP-Rac1(V12)- and EGFP-Rac1(N17)-expressing 
PANC-1 cells and coprecipitated β-catenin was 
determined by Western blotting (left panel). In paral-
lel, immunoprecipitates of EGFP/EGFP-Rac1 proteins were 
analysed for coprecipitated IQGAP1 (right panel). Staining of 
the precipitated proteins verified equal amounts of protein in 
each immunoprecipitation (lower panels) (B) Binding of 
IQGAP1 to β-catenin was confirmed by GST-pull down 
assays. GST-tagged β-catenin was incubated with 500 μg of 
lysate prepared from EGFP-, EGFP-Rac1(V12)- or EGFP-
Rac1(N17)-expressing PANC-1 cells and GST-β-catenin 
complexes were precipitated by binding to glutathione 
sepharose. Precipitated IQGAP1 and GST-β-catenin was 
determined by Western blotting. Determination of IQGAP1 
and EGFP proteins in 30 μg of the cell lysate served to dem-
onstrate equal amounts of protein in each sample. One rep-
resentative blot of three independent experiments is shown.
Analyses of Rac1/IQGAP1/β-catenin complexes in EGFP- Rac1(V12)- or EGFP-Rac1(N17)-expressing PANC-1 cells Figure 6
Analyses of Rac1/IQGAP1/β-catenin complexes in 
EGFP-Rac1(V12)- or EGFP-Rac1(N17)-expressing 
PANC-1 cells. (A) Soluble (S100) and particulate (P100) 
fractions of EGFP-, EGFP-Rac1(V12)- and EGFP-Rac1(N17)-
expressing PANC-1 cells were prepared from total cell 
lysates by centrifugation at 100000 × g. Subcellular localisa-
tion of Rac1, IQGAP1 and β-catenin was analysed in aliquots 
of 50 μg by Western blotting. To control for comparable 
loading β-actin was determined (lower panel). (B) Immuno-
precipitation was performed using 300 μg of soluble (S100) 
or particulate, membrane-containing (P100) fractions of 
PANC-1 cells stably expressing EGFP, EGFP-Rac1(V12) or 
EGFP-Rac1(N17). After immunoprecipitation of IQGAP1 
coprecipitated β-catenin and EGFP-Rac1 was determined by 
Western blotting. Detection of the immunoprecipitated 
IQGAP1 demonstrated equal amounts of protein in each 
precipitation. (C) Immunoprecipitation of β-catenin was per-
formed in parallel experiments. Coprecipitated IQGAP1 and 
EGFP-Rac1 was determined by Western blotting and detec-
tion of the immunoprecipitated β-catenin verified equal 
amounts of protein. (D) The concentration of IQGAP1 in 
PANC-1 cells was reduced by transfection of two different 
siRNA oligonucleotides targeting IQGAP1. The amount of E-
cadherin, β-catenin and IQGAP1 was demonstrated by 
Western blotting. Staining of β-actin served to demonstrate 
equal amounts of cell lysate. In each figure one representative 
blot out of three independent experiments is shown.
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plexes were determined in both the particulate and to a
higher amount in the soluble fraction (Figure 6B). These
results demonstrate that IQGAP1 interacts on the one
hand with β-catenin and EGFP-Rac1(N17) in the mem-
brane-containing fraction and on the other hand mark-
edly with constitutively active EGFP-Rac1(V12) in the
soluble fraction (Figure 6B). To verify these coimmuno-
precipitation data, β-catenin was precipitated from the
S100 and the P100 fractions and the precipitates were
analysed for coprecipitated IQGAP1 and EGFP-Rac1 by
Western blotting. The obtained results are shown in Figure
6C. In the particulate, membrane-containing fraction, β-
catenin was associated with IQGAP1 in lysates from
EGFP- and EGFP-Rac1(N17)-expressing cells but not from
EGFP-Rac1(V12)-expressing cells. An interaction of β-cat-
enin with EGFP-Rac1(V12) was found in the soluble as
well as in the particulate fraction of EGFP-Rac1(V12)-
expressing cells (Figure 6C). In the experiments exempli-
fied in Figure 6C a protein complex containing all three
proteins, namely IQGAP1, Rac1 and β-catenin was not
detectable. In summary, these data suggest the presence of
two different pools of IQGAP1 complexes. One complex
contains IQGAP1 and β-catenin and is localised in the
membrane fraction of inactive Rac1(N17)-expressing
PANC-1 cells, whereas the second is composed of
IQGAP1 and active Rac1 and is mainly situated in the sol-
uble fraction of Rac1(V12)-expressing epithelial cells.
The hypothesis that IQGAP1 stabilises the amount of E-
cadherin as well as the E-cadherin/catenin complex was
supported by experiments in which IQGAP1 expression
was downregulated by specific siRNA. The siRNA clearly
downregulated the amount of IQGAP1 on protein level
after 48 h (Figure 6D). Moreover, the E-cadherin protein
level was reduced significantly (Figure 6D), whereas the
amount of β-catenin was not altered after the knock-down
of IQGAP1, indicating a crosstalk of IQGAP1 and E-cad-
herin.
Discussion
In the present study we have analysed the influence of the
Rho-GTPase Rac1 on E-cadherin-mediated cell-cell adhe-
sion in the pancreatic carcinoma cell line PANC-1. An
enhanced expression of Rac1 has been documented for
pancreatic cancer tissue and pancreatic carcinoma cell
lines [34] and active Rac1 is necessary for cell migration
and invasion in pancreatic tumours after HGF or LPA-
stimulation [25,35]. Although many data have been col-
lected with regard to a role of Rac1 proteins in the regula-
tion of epithelial cell polarity as well as of cell-cell
adhesion complexes [36], the molecular function of Rac1
in apico-basal determination of cell polarity is still contro-
versial. [37-40]. By using pancreatic carcinoma cell clones
stably expressing constitutively active Rac1(V12), which is
constantly in its GTP-bound active form, and dominant
negative Rac1(N17), which competes with normal Rac1
for binding to guanine nucleotide exchange factors but
cannot interact with downstream effector proteins
[29,41], we demonstrate in the present manuscript the
following findings: First, constitutively active Rac1 down-
regulates E-cadherin, α-catenin and slightly β-catenin pro-
tein content and the amount of E-cadherin/catenin
adhesion complexes, inhibits E-cadherin-mediated cell-
cell aggregation and supports cellular migration and inva-
sion. Second, expression of dominant negative
Rac1(N17) results in increased amounts of E-cadherin as
well as β-catenin in pancreatic carcinoma cells, which cor-
related with a stabilisation of E-cadherin/catenin adhe-
sion complexes resulting in increased cell-cell adhesion.
These findings points to the ability of endogenous Rac1 to
modulate E-cadherin and its function. The inhibition of
endogenous Rac1 activity by a Rac1-specific inhibitor also
increased the amount of E-cadherin/β-catenin complexes.
Whereas activation of Rac1 by PDGF-treatment reduced
the amounts of E-cadherin/β-catenin complexes, thereby
supporting that the E-cadherin adhesion complex is con-
trolled by Rac1. Pharmacological inhibition of proteas-
ome-mediated E-cadherin degradation partially reverted
the effect of Rac1(V12) on E-cadherin protein content,
indicating the E-cadherin protein turnover but not its gene
expression is influenced by active Rac1 (Figure 2D+2G).
The destabilising effect of activated Rac1(V12) on cell-cell
adhesion is in agreement with studies obtained in human
keratinocytes by V. Braga and colleagues demonstrating
that microinjection of constitutively active Rac1(V12)
induced a dissociation of E-cadherin from the intercellu-
lar junctions [37,42]. Experiments by Lozano and cowork-
ers showed that the p21 activated kinase 1 (PAK1), a Rac1
effector, is also involved in the regulation of E-cadherin-
mediated cell-cell adhesion. Expression of activated Rac1
or activated PAK1(K299R) in keratinocytes leads to desta-
bilisation of the E-cadherin/catenin complexes [43]. In
addition, these data are supported by findings of Pujuguet
et al. which illustrate that phosphorylated ezrin or the
ezrin mutant T567D, which stimulated Rac1 activation in
MDCK cells, induced internalisation and degradation of
E-cadherin [44]. In contrast, expression of dominant neg-
ative Rac1(N17) stabilised E-cadherin concentration as
well as its localisation in areas of cell-cell contacts [44]. It
has been shown that clustering of endogenous E-cadherin
leads to activation of Rac1 in some cell types which is nec-
essary to form a primordial E-cadherin-mediated adhe-
sion. However, Rac1 activation is not necessary for the
maturation of these primordial adhesions to the well
described differentiated adherens junction of epithelial
cells [39,45], beyond that Rac1 activity tend to inhibit dif-
ferentiation of adherens junctions [10].Cell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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On the molecular level our data suggest that the Rac1-
effector IQGAP1 [46] mediates at least some effects
described in this study. A role for IQGAP1 in Rac1-medi-
ated regulation of E-cadherin adhesion complexes using
E-cadherin-transfected fibroblasts has been demonstrated
before by Kuroda and colleagues [47,48]. In the present
manuscript immunofluorescence analyses showed
enhanced E-cadherin and β-catenin staining in areas of
cell-cell contacts of Rac1(N17)-expressing PANC-1 cells
and a concentration of IQGAP1 in these areas. Moreover,
IQGAP1 strongly interacts with β-catenin in Rac1(N17)-
expressing PANC-1 cells. The coimmunoprecipitation of
E-cadherin with IQGAP1 (data not shown) argues for an
interaction of IQGAP1 with the E-cadherin complex via β-
catenin. The stabilising function of IQGAP1 on the turno-
ver of E-cadherin/catenin complexes was underlined by
the downregulated IQGAP1 expression by siRNAs which
resulted in a disassembly of the E-cadherin/β-catenin
complex and reduced concentration of E-cadherin in the
analysed pancreatic carcinoma cells. A recent report by
Brown and coworkers demonstrated that microinjection
of IQGAP1 mRNA into early Xenopus embryos resulted in
loss of cell-cell adhesion in the late blastula stage. In Xeno-
pus  the destabilising effect of IQGAP1 depends on its
interaction with the GTPase Cdc42 and is independent of
Rac1, which represents an example for another aspects of
IQGAP1 function [11].
β-catenin did not interact with IQGAP1 in the Rac1(V12)-
expressing cells, in which IQGAP1 colocalised with the
short actin filaments just under the plasma membrane,
where it might interact with F-actin [49]. This reduced
interaction between IQGAP1 and β-catenin is associated
with destabilised cell-cell adhesion of PANC1 pancreatic
carcinoma cells due to reduced amounts of E-cadherin/
catenin complexes. With regard to the current knowledge,
one can speculate that this reduction is likely a conse-
quence of decreased protein half life time of E-cadherin
due to an elevated turnover of E-cadherin/catenin com-
plexes [50]. The elevated turnover was suggested to be
caused by a reduced attachment of the E-cadherin com-
plex with the actin cytoskeleton in Rac1(12)-expressing
PANC-1 cells [50]. Interestingly, IQGAP1/EGFP-
Rac1(V12) complexes were found in the membrane-con-
taining and to a higher content in the cytoplasmic fraction
of PANC-1 cells, whereas IQGAP1/EGFP-Rac1(N17) com-
plexes were only detectable in the membrane-containing
fraction. EGFP-Rac1(V12) was localised in the mem-
brane-fraction and in the cytosol, which resembles the
localisation of endogenous Rac1. Several reports have
demonstrated that most of the Rac1 proteins are localised
in the cytoplasm of quiescent cells, due to a high-affinity
interaction with Rho guanine dissociation inhibitors
(RhoGDIs), especially RhoGDIα [51,52]. Activation of
Rac1 leads to dissociation of the Rac1/GDI complex and
translocation of Rac1 to the membrane [53]. Although
EGFP-Rac1(V12) is constantly in its GTP-bound form the
V12-mutant of Rac1 can still interact with GDIs, which
results in its targeting to the cytoplasmic compartment as
well. However, Rac1(N17) mutants, although locked in
the inactive conformation, have been demonstrated
exclusively in the membrane compartment (this study
and [29]). This is explained by its failure to interact with
RhoGDIα. It has been shown that dominant negative
mutants of Rho GTPases exist in a nucleotide-free state
which favours an "unproductive" interaction with GEFs at
membrane compartments (discussed in [29]). The coim-
munoprecipitation analyses performed in this study
revealed two pools of IQGAP1 complexes. IQGAP1 is
associated with β-catenin in the membrane of PANC-1
cells with low Rac1 activity where it stabilises E-cadherin/
β-catenin complexes. Moreover, IQGAP1 is associated
with active Rac1 in the soluble fraction of epithelial
PANC-1 cells, which exhibits only small amounts of E-
cadherin/β-catenin complexes. Association of IQGAP1
with active Rac1 stabilises its active conformation [54].
Previous discoveries emphasise that Rac1 controls the
subdistribution of IQGAP1 in the way that reduction of
Rac1-GTP levels decreases Rac1/IQGAP1 levels and
favours the formation of IQGAP1/β-catenin complexes
which inhibits intercellular adhesion of E-cadherin-trans-
fected L-cells [17,48,55]. Interestingly, the data presented
here are in line with a recent report on pancreatic β-cells,
in which strong cell-cell-adhesion was correlated with low
Rac1-activity along with IQGAP1-β-catenin association.
Whereas enhanced motility was associated with high Rac1
activity and IQGAP1-Rac1 interaction [55]. In β-cells
menin might be an important regulator in the differential
interaction of IQGAP1 with Rac1 or the E-cadherin-adhe-
sion complex [55]. These results point towards a cell type-
specific regulation of Rac1-E-cadherin signalling and
function depending on the availability of different
IQGAP-binding protein, such as menin. Additional stud-
ies are necessary to explain these contradictory data about
the role of Rac1 activity in cell-cell adhesion.
Based on data presented in this study as well as in several
published reports [40,55,56], we would suggest the fol-
lowing model for the role of Rac1-IQGAP in the regula-
tion of adherens junctions of epithelial pancreatic cells.
Initial local activation of Rac1, as initiated by ligation of
E-cadherin molecules located on opposing cells, is impor-
tant for adherens junction formation. But further on, Rac1
activity disturbs the development of mechanically stable
adherens junctions. IQGAP1 seems to play a key role in
this context, although the molecular details are still puz-
zling. IQGAP1 binds Rac1, especially activated Rac1, as
well as β-catenin. Our data suggest an association of
IQGAP1/β-catenin with the E-cadherin complex which
correlates with enhanced amounts of E-cadherin adhesionCell Communication and Signaling 2009, 7:23 http://www.biosignaling.com/content/7/1/23
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complexes associated with the actin cytoskeleton in epi-
thelial cells of pancreatic origin. The association of
IQGAP1 with active Rac1 results in destabilisation of
adherens junction as a cause of enhanced E-cadherin pro-
tein degradation.
Conclusion
In summary our data suggest that in pancreatic carcinoma
cells activated Rac1 interacts with IQGAP1, which is asso-
ciated with a disassembly of E-cadherin-mediated adher-
ens junctions and with increased cell migration and
invasion of pancreatic carcinoma cells. On the contrary,
prolonged reduction of Rac1 activity contributes to a sta-
bilisation of E-cadherin and E-cadherin/catenin-com-
plexes followed by increased cell-cell adhesion. This
stabilisation correlates with increased binding of IQGAP1
to the E-cadherin/catenin-complex. Our results emphasise
a regulatory role of Rac1 in promoting pancreatic tumour
cell migration and metastasis.
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